PBC Biomed had the pleasure of hosting our Clinical Advisory Board at the Medical Education & Research Institute in Memphis last week, for a development lab focused on OsStic®.


The feedback and insights shared by this group are critical in supporting our development and educational objectives for OsStic®, which was recently awarded #BreakthroughDevice Designation.

The group also looked at our other innovation programmes, including a #disruptive technology focused on nerve repair, as well as multiple new hardware concepts.

Our R&D team have been working closely with our surgeon advisors to progress these technologies through our innovation model #AIM, which is designed to drive new medical devices from concept through to commercialisation, as efficiently as possible.

For more information on AIM please visit our website here: https://lnkd.in/esGhEAFF

For more information on OsStic®, please visit the Biomimetic Innovations Ltd webpage here: https://lnkd.in/eNNgsdyA

#breakthroughdevicedesignation #FDA #boneadhesive
#provisionalfixation #osstictechnology #medicalinnovation